What is Generico?
Generico operates as a specialized healthcare brand dedicated to the mission of making essential medicines both affordable and accessible to the broader Indian population. By bridging the gap between high-cost branded pharmaceuticals and the consumer, the company serves as a critical intermediary in the healthcare supply chain. Their business model is built upon the dual pillars of consumer education regarding the efficacy of generic alternatives and the operational efficiency of a robust distribution network. This approach not only addresses the immediate financial burden of medical treatments for the general public but also fosters a more equitable healthcare ecosystem where cost is no longer a primary barrier to wellness.
How much funding has Generico raised?
Generico has raised a total of $2.9M across 3 funding rounds:
Other Financing Round
$1.4M
Series A
$136K
Debt
$1.4M
Other Financing Round (2020): $1.4M with participation from Alteria Capital
Series A (2021): $136K led by Alteria Capital
Debt (2021): $1.4M supported by Alteria Capital
Key Investors in Generico
Alteria Capital
A prominent venture debt firm specializing in providing growth capital to early and mid-stage startups across diverse technology and consumer sectors.
What's next for Generico?
With the infusion of this major enterprise-level funding, Generico is well-positioned to scale its operational footprint and deepen its market penetration. The strategic roadmap likely involves expanding its retail presence and enhancing its digital health platforms to reach underserved demographics. As the company transitions from its earlier growth phases into a more mature market participant, the focus will shift toward optimizing supply chain logistics and strengthening partnerships with generic manufacturers. This capital deployment will be instrumental in sustaining the company's trajectory as it seeks to redefine the standards of affordable healthcare delivery in a competitive and price-sensitive market.
See full Generico company page
